Evaluative performance of TyG-ABSI versus traditional indices in relation to cardiovascular disease and mortality: evidence from the U.S. National Health and Nutrition Examination Survey (NHANES)

Cardiovasc DiabetolPublished Cross-sectional and cohort study

Authors' conclusion

Our study highlights the value of TyG-ABSI in assessing cardiovascular disease and mortality risk in populations with MetS, providing new evidence for medical practice and public health interventions.

Study context

Population
Individuals with metabolic syndrome, NHANES 2001–2018
Participants
12,813 individuals
Exposure
TyG-ABSI vs TyG and other TyG-related indices
Outcome
Association of TyG-ABSI with CVD, cardiovascular mortality and all-cause mortality
Methodological detailsNHANES 2001–2018, weighted for sample design, clustering and stratification, weighted Cox proportional hazards models, weighted logistic regression
  • NHANES 2001–2018
  • Weighted for sample design, clustering and stratification
  • Weighted Cox proportional hazards models
  • Weighted logistic regression

Main finding

As reported in the abstract

CVD, cardiovascular mortality and all-cause mortality per 1-unit increase in TyG-ABSI

Increase in cardiovascular disease (CVD) risk per 1-unit increase in TyG-ABSI

28%

Increase in cardiovascular mortality per 1-unit increase in TyG-ABSI

25%

Increase in all-cause mortality per 1-unit increase in TyG-ABSI

28%

Observational data: associations, not effects.

Further findings

Predictive performance vs TyG-related indices

TyG-ABSI outperformed the traditional TyG index in overall analysis
TyG-ABSI showed superior predictive performance (ROC curve, NRI, DCA) vs other TyG-related indices

Robustness and subgroups

Competing risks models, E-value and RCS confirmed robustness; subgroup analyses supported stability with limited interaction effects

Original publication

Evaluative performance of TyG-ABSI versus traditional indices in relation to cardiovascular disease and mortality: evidence from the U.S. NHANES. Cardiovasc Diabetol. Published 21 August 2025. doi:10.1186/s12933-025-02902-6

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.